BioAtla Inc (NASDAQ: BCAB) kicked off on Friday, up 7.23% from the previous trading day, before settling in for the closing price of $0.64. Over the past 52 weeks, BCAB has traded in a range of $0.24-$2.53.
Annual sales at Healthcare sector company slipped by -10.97% over the past five years. While this was happening, its average annual earnings per share was recorded 17.13%. With a float of $45.37 million, this company’s outstanding shares have now reached $58.72 million.
BioAtla Inc (BCAB) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of BioAtla Inc is 22.73%, while institutional ownership is 15.67%.
BioAtla Inc (BCAB) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.22 earnings per share (EPS), higher than consensus estimate (set at -0.37) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.3 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 17.13% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.69% during the next five years compared to -10.97% drop over the previous five years of trading.
BioAtla Inc (NASDAQ: BCAB) Trading Performance Indicators
Take a look at BioAtla Inc’s (BCAB) current performance indicators. Last quarter, stock had a quick ratio of 1.24. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.10, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.20 in one year’s time.
Technical Analysis of BioAtla Inc (BCAB)
BioAtla Inc (NASDAQ: BCAB) saw its 5-day average volume 0.63 million, a negative change from its year-to-date volume of 0.81 million. As of the previous 9 days, the stock’s Stochastic %D was 30.71%.
During the past 100 days, BioAtla Inc’s (BCAB) raw stochastic average was set at 49.17%, which indicates a significant increase from 43.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0717 in the past 14 days, which was higher than the 0.0628 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6940, while its 200-day Moving Average is $0.4682. Nevertheless, the first resistance level for the watch stands at $0.7069 in the near term. At $0.7273, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.7657. If the price goes on to break the first support level at $0.6481, it is likely to go to the next support level at $0.6097. The third support level lies at $0.5893 if the price breaches the second support level.
BioAtla Inc (NASDAQ: BCAB) Key Stats
The company with the Market Capitalisation of 40.32 million has total of 58,722K Shares Outstanding. Its annual sales at the moment are 11,000 K in contrast with the sum of -69,780 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -18,710 K.
